JOVIC, Gordana
 Distribuzione geografica
Continente #
NA - Nord America 2.503
EU - Europa 1.318
AS - Asia 932
SA - Sud America 129
AF - Africa 30
OC - Oceania 2
Totale 4.914
Nazione #
US - Stati Uniti d'America 2.468
SG - Singapore 357
GB - Regno Unito 305
CN - Cina 258
IT - Italia 212
SE - Svezia 204
IE - Irlanda 188
DE - Germania 123
HK - Hong Kong 111
BR - Brasile 96
RU - Federazione Russa 72
VN - Vietnam 68
UA - Ucraina 60
FI - Finlandia 48
TR - Turchia 35
FR - Francia 26
IN - India 24
CA - Canada 21
LT - Lituania 21
BG - Bulgaria 19
ID - Indonesia 13
AR - Argentina 11
NL - Olanda 9
ZA - Sudafrica 9
BD - Bangladesh 8
ES - Italia 8
EC - Ecuador 7
ET - Etiopia 7
JP - Giappone 7
MX - Messico 7
IQ - Iraq 6
PL - Polonia 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
EG - Egitto 5
KR - Corea 5
IR - Iran 4
KE - Kenya 4
MY - Malesia 4
PH - Filippine 4
CO - Colombia 3
PK - Pakistan 3
SA - Arabia Saudita 3
TW - Taiwan 3
UZ - Uzbekistan 3
AU - Australia 2
BE - Belgio 2
BO - Bolivia 2
GR - Grecia 2
HU - Ungheria 2
IL - Israele 2
JO - Giordania 2
PA - Panama 2
PT - Portogallo 2
PY - Paraguay 2
VE - Venezuela 2
AL - Albania 1
AO - Angola 1
AT - Austria 1
BB - Barbados 1
BY - Bielorussia 1
BZ - Belize 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MA - Marocco 1
ME - Montenegro 1
NG - Nigeria 1
NO - Norvegia 1
OM - Oman 1
PE - Perù 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
TJ - Tagikistan 1
TN - Tunisia 1
Totale 4.914
Città #
Singapore 242
Santa Clara 236
Ashburn 223
Fairfield 219
Southend 201
Dublin 187
Chandler 182
Woodbridge 155
Houston 133
Dearborn 118
Nyköping 109
Hong Kong 106
Jacksonville 100
Seattle 86
Cambridge 81
Beijing 77
Wilmington 71
Ann Arbor 68
New York 62
London 55
Los Angeles 46
Chicago 31
Munich 27
Milan 26
Helsinki 25
Ho Chi Minh City 25
Izmir 24
Modena 24
San Diego 24
Princeton 22
Council Bluffs 20
Eugene 19
Hefei 19
Sofia 19
The Dalles 19
Hanoi 16
Moscow 16
Salt Lake City 15
Shanghai 15
Jakarta 13
Dong Ket 12
Palermo 12
Rome 12
Dallas 11
Des Moines 11
Lansdale 11
Buffalo 9
Denver 9
Turku 9
Columbus 8
Guangzhou 8
Phoenix 8
Tampa 8
Bremen 7
Brooklyn 7
Stockholm 7
Atlanta 6
Montreal 6
Boardman 5
Elk Grove Village 5
Frankfurt am Main 5
Johannesburg 5
Kunming 5
Nanjing 5
Orem 5
Porto Alegre 5
Redondo Beach 5
San Jose 5
Tokyo 5
Tulsa 5
Warsaw 5
Bari 4
Belo Horizonte 4
Bologna 4
Falls Church 4
Gallarate 4
Guayaquil 4
Norwalk 4
Ottawa 4
Redwood City 4
Rio de Janeiro 4
San Mateo 4
São Paulo 4
Augusta 3
Bangalore 3
Boston 3
Burlington 3
Chengdu 3
Chennai 3
Chiswick 3
Cremona 3
Fremont 3
Gif-sur-Yvette 3
Hounslow 3
Lancaster 3
Madrid 3
Mexicali 3
Miami 3
Mumbai 3
Nairobi 3
Totale 3.481
Nome #
Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management 373
Helicobacter pylori infection andchronic immune thrombocytopenic purpura: long-term results of bacteriumeradication and association with bacterium virulence profiles 346
Prognostic value of Dworak grade of regression (GR) in patients with rectal carcinoma treated with preoperative radiochemotherapy 345
Letrozole Versus Letrozole Plus Lapatinib (GW572016) in Hormone-Sensitive, HER2-Negative Operable Breast Cancer: A Double-Blind, Randomized Phase II Study with Biomarker Evaluation (EGF109077-LAP107692/LETLOB) 333
Phase II, randomized trial of preoperative epirubicin-paclitaxel +/- gefitinib with biomarker evaluation in operable breast cancer. 325
MODULAZIONE DELL’ESPRESSIONE DI BIOMARCATORI E PROGNOSI IN PAZIENTI AFFETTE DA CARCINOMA MAMMARIO OPERABILE SOTTOPOSTE A CHEMIOTERAPIA PREOPERATORIA 313
A prognostic model based on nodal status and Ki-67 predicts the risk of recurrence and death in breast cancer patients with residual disease after preoperative chemotherapy 305
CHER LOB Trial: Preoperative chemotherapy plus trastuzumab, lapatinib or both in HER2-positive operable breast cancer--Safety report as per Independent Data Monitoring Committee (IDMC) and preliminary activity data 289
Prognostic and Predictive Value of Baseline and Posttreatment Molecular Marker Expression in Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy 264
Preoperative chemotherapy plus lapatinib or trastuzumab or both in Her2 positive operable breast cancer. EGF109085-LAP106988/CHERLOB Trial. 259
Middle turbinate preservation versus middle turbinate resection in endoscopic surgical treatment of nasal polyposis 256
Preliminary safety data of preoperative chemotherapy plus trastuzumab, lapatinib or both in HER2-positive operable breast cancer 226
PROLIFERATION AND APOPTOSIS BEFORE AND AFTER PRIMARY SYSTEMIC THERAPY FOR OPERABLE BREAST CANCER 222
CHER-LOB: PREOPERATIVE CHEMOTHERAPY PLUS TRASTUZUMAB, LAPATINIB OR BOTH IN HER2-POSITIVE OPERABLE BREAST CANCER – PRELIMINARY SAFETY REPORT WITH FOCUS ON CARDIAC TOLERABILITY 204
COMPARISON OF HER-2 STATUS IN PRIMARY BREAST CANCER AND METASTATIC SITES: RESULTS FROM A SINGLE INSTITUTION ANALYSIS 197
Biomarker expression and survival after primary chemotherapy for breast cancer. 195
LET-LOB: preoperative letrozole plus lapatinib or placebo in hormone-receptor positive HER2 negative operable breats cancer. Preliminary report of activity and cardiac tolerability 187
CHEMOTHERAPY-INDUCED MODULATION OF BIOMARKERS EXPRESSION IN PRIMARY BREAST CANCER PATIENTS TREATED WITH PREOPERATIVE CHEMOTHERAPY 158
Final results of a phase II, double blind, placebo controlled, randomized trial of preoperative chemotherapy +/- gefitinib with biomarker evaluation in operable breast cancer 145
Totale 4.942
Categoria #
all - tutte 17.580
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.580


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021266 0 0 0 0 0 27 58 45 28 36 40 32
2021/2022394 7 52 59 23 10 32 24 13 39 17 75 43
2022/2023679 88 82 32 56 45 59 21 36 215 4 8 33
2023/2024379 18 22 22 29 81 45 23 55 16 9 33 26
2024/2025891 28 21 10 79 169 151 52 59 121 39 61 101
2025/20261.009 102 47 109 229 409 113 0 0 0 0 0 0
Totale 4.942